• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19及其症状全览:葡萄牙奥瓦尔封锁区919例疑似病例的病例对照研究

COVID-19 and Its Symptoms' Panoply: A Case-Control Study of 919 Suspected Cases in Locked-Down Ovar, Portugal.

作者信息

Sá Regina, Pinho-Bandeira Tiago, Queiroz Guilherme, Matos Joana, Ferreira João Duarte, Rodrigues Pedro Pereira

机构信息

Public Health Unit, Baixo Vouga Primary Care Cluster, Aveiro, Portugal.

CINTESIS, Faculty of Medicine, University of Porto, Porto, Portugal.

出版信息

Port J Public Health. 2021 Mar;38(3):151-158. doi: 10.1159/000514925. Epub 2021 Feb 10.

DOI:10.1159/000514925
PMID:40477548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8018191/
Abstract

BACKGROUND

Ovar was the first Portuguese municipality to declare active community transmission of SARS-CoV-2, with total lockdown decreed on March 17, 2020. This context provided conditions for a large-scale testing strategy, allowing a referral system considering other symptoms besides the ones that were part of the case definition (fever, cough, and dyspnea). This study aims to identify other symptoms associated with COVID-19 since it may clarify the pre-test probability of the occurrence of the disease.

METHODS

This case-control study uses primary care registers between March 29 and May 10, 2020 in Ovar municipality. Pre-test clinical and exposure-risk characteristics, reported by physicians, were collected through a form, and linked with their laboratory result.

RESULTS

The study population included a total of 919 patients, of whom 226 (24.6%) were COVID-19 cases and 693 were negative for SARS-CoV-2. Only 27.1% of the patients reporting contact with a confirmed or suspected case tested positive. In the multivariate analysis, statistical significance was obtained for headaches (OR 0.558), odynophagia (OR 0.273), anosmia (OR 2.360), and other symptoms (OR 2.157). The interaction of anosmia and odynophagia appeared as possibly relevant with a borderline statistically significant OR of 3.375.

CONCLUSION

COVID-19 has a wide range of symptoms. Of the myriad described, the present study highlights anosmia itself and calls for additional studies on the interaction between anosmia and odynophagia. Headaches and odynophagia by themselves are not associated with an increased risk for the disease. These findings may help clinicians in deciding when to test, especially when other diseases with similar symptoms are more prevalent, namely in winter.

摘要

背景

奥瓦尔是葡萄牙首个宣布出现严重急性呼吸综合征冠状病毒2(SARS-CoV-2)社区传播的市,2020年3月17日颁布了全面封锁令。这种情况为大规模检测策略提供了条件,使得在病例定义(发热、咳嗽和呼吸困难)之外,还能考虑其他症状的转诊系统得以实施。本研究旨在确定与2019冠状病毒病(COVID-19)相关的其他症状,因为这可能会阐明该疾病发生的检测前概率。

方法

本病例对照研究使用了2020年3月29日至5月10日奥瓦尔市的基层医疗记录。医生报告的检测前临床和暴露风险特征通过一份表格收集,并与他们的实验室结果相关联。

结果

研究人群共有919名患者,其中226例(24.6%)为COVID-19病例,693例SARS-CoV-2检测呈阴性。报告与确诊或疑似病例有接触的患者中,只有27.1%检测呈阳性。在多变量分析中,头痛(比值比[OR]0.558)、吞咽痛(OR 0.273)、嗅觉丧失(OR 2.360)和其他症状(OR 2.157)具有统计学意义。嗅觉丧失和吞咽痛的相互作用似乎可能相关,其OR为3.375,具有边缘统计学意义。

结论

COVID-19有广泛的症状。在众多已描述的症状中,本研究突出了嗅觉丧失本身,并呼吁对嗅觉丧失和吞咽痛之间的相互作用进行更多研究。头痛和吞咽痛本身与该疾病风险增加无关。这些发现可能有助于临床医生决定何时进行检测,特别是在其他具有相似症状的疾病更为普遍时,即在冬季。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/8018191/bb33e1de9662/pjp-0038-0151-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/8018191/bb33e1de9662/pjp-0038-0151-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bbf/8018191/bb33e1de9662/pjp-0038-0151-g01.jpg

相似文献

1
COVID-19 and Its Symptoms' Panoply: A Case-Control Study of 919 Suspected Cases in Locked-Down Ovar, Portugal.COVID-19及其症状全览:葡萄牙奥瓦尔封锁区919例疑似病例的病例对照研究
Port J Public Health. 2021 Mar;38(3):151-158. doi: 10.1159/000514925. Epub 2021 Feb 10.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
4
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.
5
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
6
Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.在六个国家数字监测平台上,与 SARS-CoV-2 检测呈阳性相关的嗅觉丧失、味觉丧失和其他类似 COVID-19 的症状:一项观察性研究。
Lancet Digit Health. 2021 Sep;3(9):e577-e586. doi: 10.1016/S2589-7500(21)00115-1. Epub 2021 Jul 22.
7
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
8
SARS-CoV-2 infection in children and adolescents: a Brazilian experience.儿童和青少年感染 SARS-CoV-2:巴西的经验。
Rev Paul Pediatr. 2022 May 6;40:e2021172. doi: 10.1590/1984-0462/2022/40/2021172IN. eCollection 2022.
9
Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.SARS-CoV-2 感染幸存者的流行病学和临床特征:一项描述性研究。
Medwave. 2022 Oct 25;22(9):e2581. doi: 10.5867/medwave.2022.09.2581.
10
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.

本文引用的文献

1
A review of smell and taste dysfunction in COVID-19 patients.新冠病毒感染患者嗅觉和味觉功能障碍综述。
Med J Malaysia. 2020 Sep;75(5):574-581.
2
Spectrum of Neurological Manifestations in Covid-19: A Review.Covid-19 相关神经系统表现的综述。
Neurol India. 2020 May-Jun;68(3):560-572. doi: 10.4103/0028-3886.289000.
3
COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.新型冠状病毒肺炎:特异性和非特异性临床表现及症状:当前的知识现状
J Clin Med. 2020 Jun 5;9(6):1753. doi: 10.3390/jcm9061753.
4
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.成年 SARS-CoV-2 感染患者新发嗅觉丧失和味觉丧失。
Clin Microbiol Infect. 2020 Sep;26(9):1236-1241. doi: 10.1016/j.cmi.2020.05.026. Epub 2020 Jun 2.
5
Anosmia in COVID-19 patients.新冠病毒感染患者的嗅觉丧失
Clin Microbiol Infect. 2020 Oct;26(10):1426-1427. doi: 10.1016/j.cmi.2020.05.017. Epub 2020 May 22.
6
Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.新型冠状病毒肺炎患者急性嗅觉或味觉丧失的流行率和持续时间。
J Korean Med Sci. 2020 May 11;35(18):e174. doi: 10.3346/jkms.2020.35.e174.
7
Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.COVID-19 的皮肤表现:三例病例报告及文献复习。
J Dermatol Sci. 2020 May;98(2):75-81. doi: 10.1016/j.jdermsci.2020.04.011. Epub 2020 Apr 29.
8
The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis.新冠病毒患者嗅觉和味觉功能障碍的流行情况:系统评价和荟萃分析。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11. doi: 10.1177/0194599820926473. Epub 2020 May 5.
9
Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.嗅觉减退和味觉减退对新型冠状病毒肺炎诊断的效用。
Lancet Infect Dis. 2020 Sep;20(9):1014-1015. doi: 10.1016/S1473-3099(20)30297-8. Epub 2020 Apr 15.
10
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.嗅觉和味觉障碍作为冠状病毒病(COVID-19)轻至中度形式的临床特征:一项多中心欧洲研究。
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.